FF:0000361: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|comment= | |comment= | ||
|created_by= | |created_by= | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0000361 | |||
|is_a=UO:0000032 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=4 hr | |||
|namespace=FANTOM5 | |||
|obo_creation_date= | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym= | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Revision as of 10:39, 12 September 2014
outline
- id: FF:0000361
- name: 4 hr
- namespace: FANTOM5
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | UO:0000032(hour) |
|---|
Children
| is a: | FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000509 (mouse J2E erythroblastic leukemia line 4hr after treatment with erythropoietin sample),FF:0000525 (human K562 erythroblastic leukemia line 4hr after treatment with hemin sample),FF:0000553 (human Aortic Smooth Muscle cells 4hr after treatment with FGF2 sample),FF:0000563 (human Aortic Smooth Muscle cells 4hr after treatment with IL1b sample),FF:0000577 (human Monocyte-derived macrophages 4h after LPS treatment sample),FF:0000603 (human Saos2 osteosarcoma cell line 4h after induction of calcification with ascorbate and BPG sample),FF:0000614 (mouse EBF KO HPCs induced to T cell 4h sample),FF:0000721 (Saos2 osteosarcoma cell line 4h untreated control),FF:0011233 (mouse tracheal ciliated cells differentiation after 4hr sample),FF:3568-170I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3578-170A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3588-170B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3598-170C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb),FF:3640-171I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3650-171A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3660-171B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3670-171C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb, 004hr, biol_rep2),FF:3705-172B1 (macrophage, TB infection, non-stimulated BMDM, without Mtb),FF:3971-173H4 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb) |
|---|
FF Samples
Mouse
- 3568-170I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph))
- 3578-170A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb)
- 3588-170B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb)
- 3598-170C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb)
- 3640-171I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph))
- 3650-171A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb)
- 3660-171B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb)
- 3670-171C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb, 004hr, biol_rep2)
- 3705-172B1 (macrophage, TB infection, non-stimulated BMDM, without Mtb)
- 3971-173H4 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb)
